Thrombin inhibitors are anticoagulants that bind to and inhibit the activity ofthrombin therefore prevent blood clot formation. Thrombin inhibitors inactivate freethrombin and also the thrombin that is bound to fibrin.
This report contains market size and forecasts of Thrombin Inhibitor in global, including the following market information:
Global Thrombin Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thrombin Inhibitor Market Sales, 2017-2022, 2023-2028, (K Pieces)
Global top five Thrombin Inhibitor companies in 2021 (%)
The global Thrombin Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Argatroban Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thrombin Inhibitor include Bristol-Myers Squibb, Bayer, Sanofi, Genentech, CSL, Abbott, Armetheon, Microbix Biosystems and Astrazeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombin Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thrombin Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Thrombin Inhibitor Market Segment Percentages, by Type, 2021 (%)
Argatroban
Activase
Others
Global Thrombin Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Thrombin Inhibitor Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialist Clinic
Others
Global Thrombin Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Thrombin Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thrombin Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thrombin Inhibitor revenues share in global market, 2021 (%)
Key companies Thrombin Inhibitor sales in global market, 2017-2022 (Estimated), (K Pieces)
Key companies Thrombin Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Bayer
Sanofi
Genentech
CSL
Abbott
Armetheon
Microbix Biosystems
Astrazeneca
Baxter
Emisphere Technologies
Johnson & Johnson
Merck